Inspire Medical Systems Long Term Debt 2017-2025 | INSP
|
Inspire Medical Systems Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | $16 |
| 2020 | $25 |
| 2019 | $25 |
| 2018 | $25 |
| 2017 | $16 |
| 2016 | |
|
Inspire Medical Systems Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-06-30 | |
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | $10 |
| 2022-03-31 | $13 |
| 2021-12-31 | $16 |
| 2021-09-30 | $19 |
| 2021-06-30 | $22 |
| 2021-03-31 | $25 |
| 2020-12-31 | $25 |
| 2020-09-30 | $25 |
| 2020-06-30 | $25 |
| 2020-03-31 | $25 |
| 2019-12-31 | $25 |
| 2019-09-30 | $24 |
| 2019-06-30 | $24 |
| 2019-03-31 | $24 |
| 2018-12-31 | $25 |
| 2018-09-30 | $25 |
| 2018-06-30 | $22 |
| 2018-03-31 | $24 |
| 2017-12-31 | $16 |
| 2017-09-30 | |
| 2017-06-30 | |
| 2017-03-31 | |
| 2016-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $2.501B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||